Research Articles
The Invisible Shield: How a Tiny Genetic Variation Shapes Health in Hispanic Populations
Discover how A20 (TNFAIP3) genetic variations impact inflammation and autoimmune disease risks in Hispanic populations through groundbreaking research.
Shattering Cancer's Defenses: The PROTAC Revolution Targeting MLK3
Discover how PROTAC technology is revolutionizing cancer therapy by targeting MLK3 in triple-negative breast cancer, offering hope against treatment-resistant tumors.
The Evergreen Energy Revolution: Supercharged Switchgrass Takes Root
Discover how genetically modified switchgrass with elevated miR156 levels produces 250% more biomass while offering natural bioconfinement for sustainable biofuel production.
The Metastasis Breaker: How Silencing a Tiny Enzyme Could Halt Cancer's Spread
Groundbreaking research on SIAH2 inhibition as a promising approach to contain metastatic spread in treatment-resistant cancers.
Sabotaging the Sentinel: How Adenovirus Hijacks the Cell's DNA Damage Alarm
Explore how adenoviruses disrupt the cellular DNA Damage Response (DDR) pathway to enable viral replication, with implications for cancer therapy.
The Stealth Saboteur: How Pancreatic Cancer Hijacks Muscle Maintenance via IGFBP-3
Groundbreaking research reveals how tumor-derived IGFBP-3 drives muscle wasting in pancreatic cancer patients through metabolic hijacking.
The Double Life of HIF-1α: How Cellular Survival Mechanisms Turn Traitor
Exploring how HIF-1α's survival mechanisms can become pathological when activated by TOR and SMAD pathways in cancer, autoimmunity, and fibrosis.
BAP1: The Unsung Hero in Lung Cancer's Molecular Battlefield
Exploring BAP1's role as a prognostic biomarker and therapeutic target in non-small cell lung cancer (NSCLC)
The Hidden Conductor: How a Tiny RNA Steers Stem Cell Destiny
Discover how the lncRNA ESRG regulates TCF3 alternative splicing to maintain human embryonic stem cell pluripotency and self-renewal.
The Lipid Linchpin: How a Metabolic Mastermind Fuels Lung Cancer's Deadliest Cells
Exploring how SCD1's manipulation of cellular architecture through YAP/TAZ fuels lung cancer stem cells and drives recurrence.